Senior insider sale
PRESIDENT & CFO at XENON PHARMACEUTICALS INC. — senior position signals high conviction
$19.15M
328.58K shares
What this filing means
MORTIMER IAN plans to sell 328.58K shares of XENON PHARMACEUTICALS INC. valued at approximately $19.15M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 3/13/2026ACC: 0001193125-26-106680
Officer· PRESIDENT & CFO
Since Sep 2019
328.58K
Shares to sell
$19.15M
Approx. market value
12.50K
Acquired (3 months)
1
Planned
3 completed
Securities Acquired — Last 3 Months1
Restricted share unit award vesting
N/A
3/12/2026
12.50KTotal acquired12.50K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
3/12/2026 | Restricted share unit award vesting N/A | 12.50K | — |
| Total | 12.50K | ||
Planned & Completed Dispositions4
Completed
—Completed
Units to sell
11.27K
Market value
$677.4K
3/10/2026
—Completed
Units to sell
270K
Market value
$16.29M
3/9/2026
—Completed
Units to sell
40K
Market value
$1.78M
1/2/2026
Planned — Approximate Date
NASDAQPlanned
Units to sell
7.31K
Market value
$403.6K
3/13/2026
Total
Units
328.58K
Value
$19.15M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
3/10/2026 | 11.27K | $677.4K | — | Completed |
3/9/2026 | 270K | $16.29M | — | Completed |
1/2/2026 | 40K | $1.78M | — | Completed |
| Planned — Approximate Date | ||||
3/13/2026 | 7.31K | $403.6K | NASDAQ | Planned |
| Total | 328.58K | $19.15M | ||